IGC Reports Financial Results for the Fiscal Year Ended March 31, 2019 - IGC Pharma, INC.

Press

Releases

June 14, 2019

IGC Reports Financial Results for the Fiscal Year Ended March 31, 2019

Related Posts

IGC Pharma’s Puerto Rico CALMA Trial Site Offers Strategic Opportunity in High-Prevalence Alzheimer’s Market

May 22, 2025

IGC Pharma Presents Genetic Toxicology Safety Data on API in IGC-AD1, at the 2025 Genetic Toxicology Association Meeting

May 12, 2025

IGC Pharma Welcomes Strategic Investment from Advisors

April 24, 2025

CEO Update

igc pharma

IGC Pharma Inc 8K – Clinical Study Update Jun 17’25

June 17, 2025

IGC Pharma’s Puerto Rico CALMA Trial Site Offers Strategic Opportunity in High-Prevalence Alzheimer’s Market

May 22, 2025